Therefore, it is possible that chronic inflammation associated with HCV infection shifts hepatocytic TGF-β signaling from tumor suppression to fibrogenesis, accelerating liver fibrosis and increasing the risk of HCC. This evidence concerns the gene TGFB1 and neoplasm.